Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-26

FDA Approved: XALKORI — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved XALKORI (crizotinib) through an original application by Pfizer Laboratories Div Pfizer Inc. This marks the initial FDA approval of crizotinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xalkori (crizotinib)

Snippet

ORIG AP for XALKORI (CRIZOTINIB)